GL1X · GenesisL1 explorer

MolNFT v1 · #7856 · protein

Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine protease drug targets

1GJB · Urokinase-type plasminogen activator: “Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine protease drug targets”. X-ray diffraction, 1 ligand (130), 1 pocket (best druggability 0.41). MolNFT v1…

PDB
1GJB
Type
protein
Length
254 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator
EC
3.4.21.73
UniProt
P00749
Ligands
130
Pockets
1 · best druggability 0.41

Structure

x-ray diffraction · 2 distinct chains · 11% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activatorprotein80% helix, 0% strandP00749
BUrokinase-type plasminogen activator (EC 3.4.21.73)protein24611% helix, 39% strandP00749

Ligands and binding sites

  • 130 · 2-(2-hydroxy-biphenyl)-1H-benzoimidazole-5-carboxamidine · ligand · chains B
  • CIT · Citric acid · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11190.410.7631130

Interfaces

1 interface between chains.

  • A–B · 451 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1GJB · Engineering inhibitors highly selective for the S1 sites of SER190 trypsin-like serine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.